Company Overview of Cebix Incorporated
Cebix Incorporated is a biopharmaceutical company that focuses on the treatment of diabetic complications, including those affecting the function of nerves, kidneys, and eyes. The company develops Ersatta, a disease-modifying replacement peptide for the treatment of complications associated with diabetes. Its Ersatta is a once-weekly C-peptide therapy to target loss of nerve function and other vascular complications in Type 1 diabetes patients. The company was incorporated in 2008 and is based in San Diego, California.
12520 High Bluff Drive
San Diego, CA 92130
Founded in 2008
Key Executives for Cebix Incorporated
Cebix Incorporated Key Developments
Similar Private Companies By Industry
|AmbioPharm, Inc.||United States|
|Western Oncolytics Ltd.||United States|
|Nelco Laboratories, Inc.||United States|
|AREVA Med LLC||United States|
|Emergent Product Development Seattle LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Cebix Incorporated, please visit www.cebix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.